Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma

BACKGROUND: The first line therapy for patients with diffuse large B cell (DLBCL) is R-CHOP. About half of DLBCL patients are either refractory to, or will relapse, after the treatment. Therefore, identifying novel drug targets and effective therapeutic agents is urgently needed for improving DLBCL...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Exp Clin Cancer Res
Autori principali: Jiang, Liling, Sun, Yuening, Wang, Jinxiang, He, Qingyan, Chen, Xinmei, Lan, Xiaoying, Chen, Jinghong, Dou, Q. Ping, Shi, Xianping, Liu, Jinbao
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6836452/
https://ncbi.nlm.nih.gov/pubmed/31694672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1446-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi